These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4860334)

  • 1. The beta-adrenergic blocking agents pharmacology and structure-activity relationships.
    Biel JH; Lum BK
    Fortschr Arzneimittelforsch; 1966; 10():46-89. PubMed ID: 4860334
    [No Abstract]   [Full Text] [Related]  

  • 2. The structure-activity relationships of beta adrenergic drugs and beta adrenergic blocking drugs.
    Ariëns EJ
    Ann N Y Acad Sci; 1967 Feb; 139(3):606-31. PubMed ID: 5342360
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of beta-adrenergic blocking agents.
    Lucchesi BR; Whitsitt LS
    Prog Cardiovasc Dis; 1969 Mar; 11(5):410-30. PubMed ID: 4892569
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationship of the beta adrenoreceptor blocking agents.
    Laddu AR; Somani P
    Eur J Pharmacol; 1969 Nov; 8(2):167-70. PubMed ID: 4391503
    [No Abstract]   [Full Text] [Related]  

  • 5. New beta-adrenergic blocking agents. Cyclopropylphenyl derivatives.
    Boissier JR; Ratouis R; Dumont C; Derible PH; Lavaux JP
    J Med Chem; 1970 Sep; 13(5):971-3. PubMed ID: 4394057
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on new -adrenergic blocking agents. I. Syntheses and pharmacology of coumarin derivatives.
    Sato Y; Kobayashi Y; Nagasaki T; Oshima T; Kumakura S
    Chem Pharm Bull (Tokyo); 1972 May; 20(5):905-17. PubMed ID: 4403400
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-adrenergic blocking agents. IV. Variation of the 2-naphthyl group of pronethalol (2-isopropylamino-1-(2-naphthyl)ethanol).
    Howe R; McLoughlin BJ; Rao BS; Smith LH; Chodnekar MS
    J Med Chem; 1969 May; 12(3):452-8. PubMed ID: 4389217
    [No Abstract]   [Full Text] [Related]  

  • 8. ADRENERGIC NEURONE BLOCKING ACTIVITY OF SOME ARALKYLGUANIDINES.
    FIELDEN R; GREEN AL; WILEY GL
    Br J Pharmacol Chemother; 1965 Apr; 24(2):395-407. PubMed ID: 14320854
    [No Abstract]   [Full Text] [Related]  

  • 9. Steric aspects of adrenergic drugs. V. Beta adrenergic blocking effects of optical isomers of methoxamine and isopropylmethoxamine.
    Patil PN; Tye A; LaPidus JB
    J Pharmacol Exp Ther; 1967 Jun; 156(3):445-51. PubMed ID: 6027454
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs.
    Dollery CT; Paterson JW; Conolly ME
    Clin Pharmacol Ther; 1969; 10(6):765-99. PubMed ID: 4390767
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-adrenergic receptor-blocking properties of six phenethylamine derivatives in vitro.
    Ghouri MS; Haley TJ
    J Pharm Sci; 1969 Jun; 58(6):760-1. PubMed ID: 5799770
    [No Abstract]   [Full Text] [Related]  

  • 12. The development of beta adrenergic blocking drugs: a retrospective and prospective evaluation.
    Moran NC
    Ann N Y Acad Sci; 1967 Feb; 139(3):649-60. PubMed ID: 4382726
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of beta adrenergic blocking agents on the noradrenaline content of rat heart before and after noradrenaline infusion.
    Westfall TC
    Eur J Pharmacol; 1967 Dec; 2(3):163-8. PubMed ID: 5591515
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationship in a series of adrenergic beta-blocking agents related to 1-(4-nitrophenyl)-1-hydroxy-2-isopropylaminoethane (INPEA).
    Somani P; Bachand RT; Murmann W; Almirante L
    J Med Chem; 1966 Nov; 9(6):823-5. PubMed ID: 5972037
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacology of beta-receptor-blocking drugs.
    Dollery CT; Paterson JW; Conolly ME
    Clin Pharmacol Ther; 1969; 10(6):765-99. PubMed ID: 4393717
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide).
    DORNHORST AC; ROBINSON BF
    Lancet; 1962 Aug; 2(7251):314-6. PubMed ID: 13887414
    [No Abstract]   [Full Text] [Related]  

  • 17. STRUCTURE-ACTIVITY RELATIONSHIPS OF 1-((3-INDOLYL)ALKYL)-4- ARYLPIPERAZINES. A NEW SERIES OF TRANQUILIZERS.
    WYLIE DW; ARCHER S
    J Med Pharm Chem; 1962 Sep; 5():932-43. PubMed ID: 14056437
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide).
    BLACK JW; STEPHENSON JS
    Lancet; 1962 Aug; 2(7251):311-4. PubMed ID: 13869657
    [No Abstract]   [Full Text] [Related]  

  • 19. [Optical antipodes of adrenergic beta receptor blocking agent 1-(o-allyloxyphenoxy)-3-isopropylamino-2-propanol].
    Meier M; Hedwall PR; Imhof P; Wilhelm M; Brunner H
    Arzneimittelforschung; 1970 Dec; 20(12):1890-6. PubMed ID: 4395650
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship between adrenergic neurone blocking activity and local anaesthetic activity in a series of guanidine derivatives.
    Rand MJ; Wilson J
    Eur J Pharmacol; 1967 May; 1(3):200-9. PubMed ID: 6069945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.